Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/99/9f/e4/999fe482-6bc3-87ba-4c11-ec03e2c84a5f/mza_8207740883797533531.jpg/600x600bb.jpg
AJT Highlights
American Journal of Transplantation
94 episodes
1 week ago
Show more...
Medicine
Health & Fitness
RSS
All content for AJT Highlights is the property of American Journal of Transplantation and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/99/9f/e4/999fe482-6bc3-87ba-4c11-ec03e2c84a5f/mza_8207740883797533531.jpg/600x600bb.jpg
AJT October 2025 Editors’ Picks
AJT Highlights
46 minutes
1 month ago
AJT October 2025 Editors’ Picks
AJT October 2025 Editors’ Picks Description:  Hosts Roz and Dr. Sanchez-Fueyo are joined by Dr. Christina Haugen to discuss the key articles of the October issue of the American Journal of Transplantation. Dr. Christina Haugen is an Assistant Professor of Surgery at the University of Cincinnati. [03:28] Renal resistance trajectories during hypothermic machine perfusion in kidneys donated after circulatory death: Associations with donor characteristics and posttransplant outcomes—An analysis of COMPARE trial data [10:26] Donor-specific mesenchymal stem cell infusion in human and nonhuman primate kidney transplantation [19:21] Potential targeting of urokinase-type plasminogen activator receptor–formyl peptide receptor signaling to prevent recurrence in posttransplant primary podocytopathies [30:20] The relationship between cessation of brain and systemic circulation after withdrawal of life-sustaining measures [36:03] Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction
AJT Highlights